Antigen-Specific vs. Neutralizing Antibodies Against Conditioned Media of Patients With Clostridioides difficile Infection: A Prospective Exploratory Study
Open Access
- 24 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 13, 859037
Abstract
The immunological response against Clostridioides difficile (C. difficile) is crucial for an improved understanding of disease mechanisms and the development of novel therapeutic strategies. From April 2014 to February 2015, adult patients with C. difficile infection (CDI) were recruited, and the clinical course and treatment response were carefully monitored. On day 1, 3, and 6 after diagnosis, patient plasma samples were screened for anti-GDH (glutamate dehydrogenase), anti-TcdA, anti-TcdB, and anti-CWP84 (cell-wall protein 84) antibodies by ELISA. Additionally, neutralization assays of toxins from conditioned media of clinical isolates (RT010, RT014, and RT027) were performed. Most patients with CDI (n = 46) had antibodies against GDH (85%) and CWP84 (61%), but only few had antibodies against TcdA (11%) and TcdB (28%). We found patients with neutralizing antibodies against C. difficile toxins (conditioned media) produced by RT027 (26%). A subgroup of these samples could neutralize both toxins from RT027 and RT014 [11%, (5/46)]; however, no single sample neutralized only RT014. Overall, neutralizing antibody titers were low (≤1:16). In a one week follow-up of acute infection, we never observed an early booster effect with seroconversion or antibody increases, irrespective of disease severity. No correlation was found between the presence of antigen-specific (ELISA) or neutralizing antibodies and the clinical course of disease. Anti-TcdB but not anti-TcdA antibodies correlated with the occurrence of neutralizing antibodies. In conclusion, natural antibody titers against C. difficile toxins were absent or low and were not associated with disease severity. The correlation between the anti-TcdB with toxin neutralization confirms the importance of TcdB for virulence of CDI. Alternative sensitization strategies, e.g., through vaccine development, are required to overcome the regular low-titer antibody production following natural intestinal C. difficile exposure.Keywords
This publication has 27 references indexed in Scilit:
- Clostridium difficile glutamate dehydrogenase is a secreted enzyme that confers resistance to H2O2Microbiology, 2014
- IgG Antibody Response to Toxins A and B in Patients with Clostridium difficile InfectionClinical and Vaccine Immunology, 2012
- Host and Pathogen Factors forClostridium difficileInfection and ColonizationNew England Journal of Medicine, 2011
- The host immune response to Clostridium difficileJournal of Medical Microbiology, 2011
- Roles of Cysteine Proteases Cwp84 and Cwp13 in Biogenesis of the Cell Wall of Clostridium difficileJournal of Bacteriology, 2011
- Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controlsJournal of Medical Microbiology, 2008
- Heterogeneity of large clostridial toxins: importance ofClostridium difficiletoxinotypesFEMS Microbiology Reviews, 2008
- Variability of Clostridium difficile Surface Proteins and Specific Serum Antibody Response in Patients with Clostridium difficile -Associated DiseaseJournal of Clinical Microbiology, 2005
- Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoeaThe Lancet, 2001
- Immunoglobulin G directed against toxins A and B of Clostridium difficile in the general population and patients with antibiotic-associated diarrheaDiagnostic Microbiology and Infectious Disease, 1994